Drug Trial Radar · NCT06064097
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Jun 25, 2024
Primary completion
Mar 31, 2027
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Oct 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Researchers want to find out what effects, good and/or bad, adding nivolumab to chemotherapy has on patients with newly diagnosed NPC. In addition, they want to find out if children with NPC may be treated with less radiation therapy and whether this decreases the side effects of therapy.
Conditions
- Stage II Nasopharyngeal Carcinoma AJCC v8
- Stage III Nasopharyngeal Carcinoma AJCC v8
- Stage IV Nasopharyngeal Carcinoma AJCC v8
Interventions
Biopsy ProcedureProcedure
Undergo tissue biopsy
Biospecimen CollectionProcedure
Undergo blood sample collection
Chest RadiographyProcedure
Undergo chest x-ray
CisplatinDrug
Given IV
Computed TomographyProcedure
Undergo CT
Echocardiography TestProcedure
Undergo ECHO
Electronic Health Record ReviewOther
Ancillary studies
Fluciclovine F18Other
Given IV
GemcitabineDrug
Given IV
Magnetic Resonance ImagingProcedure
Undergo MRI
Multigated Acquisition ScanProcedure
Undergo MUGA
NivolumabBiological
Given IV
Positron Emission TomographyProcedure
Undergo PET
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
Radiation TherapyRadiation
Receive radiation therapy
X-Ray ImagingProcedure
Undergo dental x-ray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of grade 3 or higher immune-related adverse events (irAE) during induction chemoimmunotherapy (CIT)Time frame: Until the end of consolidation therapy
Locations
86 sites in 5 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama · Recruiting
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Kaiser Permanente Downey Medical Center
Downey, California · Recruiting
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Valley Children's Hospital
Madera, California · Recruiting
UCSF Benioff Children's Hospital Oakland
Oakland, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Medical Center-Mission Bay
San Francisco, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Alfred I duPont Hospital for Children
Wilmington, Delaware · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
UF Health Cancer Institute - Gainesville
Gainesville, Florida · Recruiting
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida · Recruiting
Nicklaus Children's Hospital
Miami, Florida · Recruiting
Arnold Palmer Hospital for Children
Orlando, Florida · Recruiting
Nemours Children's Hospital
Orlando, Florida · Recruiting
Nemours Children's Clinic - Pensacola
Pensacola, Florida · Recruiting
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida · Recruiting
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia · Recruiting
Lurie Children's Hospital-Chicago
Chicago, Illinois · Recruiting
University of Chicago Comprehensive Cancer Center
Chicago, Illinois · Suspended
Riley Hospital for Children
Indianapolis, Indiana · Recruiting
University of Kentucky/Markey Cancer Center
Lexington, Kentucky · Not yet recruiting
Children's Hospital New Orleans
New Orleans, Louisiana · Recruiting
Maine Children's Cancer Program
Scarborough, Maine · Recruiting
Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore, Maryland · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids, Michigan · Recruiting
Mayo Clinic in Rochester
Rochester, Minnesota · Recruiting
University of Mississippi Medical Center
Jackson, Mississippi · Recruiting
Children's Mercy Hospitals and Clinics
Kansas City, Missouri · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Children's Hospital and Medical Center of Omaha
Omaha, Nebraska · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Hackensack University Medical Center
Hackensack, New Jersey · Recruiting
Jersey Shore Medical Center
Neptune City, New Jersey · Recruiting
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.